NASDAQ · FORA
Healthcare · Medical - Healthcare Information Services
$2.17
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 1:08 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
FORA does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning FORA.
FORA research
Company profile and research snapshot.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 14, 2024 | Roth MKM | Buy | — |
| Apr 4, 2024 | Roth MKM | Buy | — |
| Dec 20, 2023 | Roth MKM | Buy | — |
| Aug 11, 2023 | Lake Street | Buy | — |
| Nov 10, 2022 | RBC Capital | Outperform | — |
No generated briefing is available yet.
defenseworld.net · Nov 18, 2025
VerticalScope Holdings Inc. (TSE: FORA - Get Free Report) has been given a consensus rating of "Hold" by the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning FORA.
